Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline Alfoscerate for Subthreshold Depression in the Elderly
2025-520899-25-00Phase 4Authorised
- Sponsor
- ASST Lodi
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of choline alfoscerate in major depressive disorder (MDD), sponsored by ASST Lodi. Primary endpoint: Change in HAMD-17 score from baseline to final visit. Planned start Jan 2025; status: authorised.
02
Drugs
choline alfoscerate
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2025-520899-25-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520899-25-00.